NOVABAY PHARMACEUTICALS INC (NBY)

Company Profile

NovaBay Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Emeryville, California and currently employs 24 full-time employees. The company went IPO on 2007-10-26. NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and wound care products. Its product, Avenova Antimicrobial Lid and Lash Solution, has antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. The company offers a portfolio of products for each step of the standard at home treatment regimen, including the Avenova Eye Health Support antioxidant-rich oral supplement, Avenova Lubricating Eye Drops for instant relief, NovaWipes by Avenova, Avenova Warm Eye Compress to soothe the eyes, and the i-Chek by Avenova to monitor physical eyelid health. The company also manufactures and sells its proprietary form of hypochlorous acid for the wound care market with its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers and other injuries.

Company Info

NOVABAY PHARMACEUTICALS INC

2000 Powell St Ste 1150

Emeryville CALIFORNIA 94608

P: 15108998800

CEO: Justin Hall

Employees: 25

Website: https://novabay.com/